Development of an immunomodulatory biomaterial: Using resolvin D1 to modulate inflammation
- 1 June 2015
- journal article
- Published by Elsevier in Biomaterials
- Vol. 53, 566-573
Abstract
No abstract availableKeywords
Funding Information
- FEDER funds (PTDC/SAU-BMA/113030/2009)
- QREN (NORTE-07-0124-FEDER-000005)
This publication has 31 references indexed in Scilit:
- Spinal Actions of Lipoxin A4 and 17(R)-Resolvin D1 Attenuate Inflammation-Induced Mechanical Hypersensitivity and Spinal TNF ReleasePLOS ONE, 2013
- A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung InflammationPLOS ONE, 2013
- Macrophage polarization: An opportunity for improved outcomes in biomaterials and regenerative medicineBiomaterials, 2012
- Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materialsActa Biomaterialia, 2012
- Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like PhenotypeThe Journal of Immunology, 2011
- Immune responses to implants – A review of the implications for the design of immunomodulatory biomaterialsBiomaterials, 2011
- Macrophage and dendritic cell phenotypic diversity in the context of biomaterialsJournal of Biomedical Materials Research Part A, 2010
- Lipoxins: resolutionary roadBritish Journal of Pharmacology, 2009
- Inflammation in Wound Repair: Molecular and Cellular MechanismsJournal of Investigative Dermatology, 2007
- Increased inflammatory reactivity in newly formed lining tissueThe Journal of Pathology, 1983